NCT02337101

Brief Summary

Background: Five - 15 % of patients with concussion continue to experience impairing physical, cognitive and emotional symptoms longer than 3 months post-injury. Currently, no standardised treatment is available for patients with persistent post-concussional symptoms (PCS) and systematic treatment studies remain limited. Aim:

  1. 1.to develop an early intervention programme based on principles from cognitive-behavioural therapy and graded exercise for young patients with PCS lasting more than 3 months, and
  2. 2.to evaluate the efficacy of this intervention on PCS in a randomised, controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 13, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

September 26, 2019

Status Verified

January 1, 2019

Enrollment Period

3.3 years

First QC Date

January 8, 2015

Last Update Submit

September 25, 2019

Conditions

Keywords

Brain concussionMild Traumatic Brain InjuryPost-concussion symptomsTherapyRandomised controlled trialCognitive assessment

Outcome Measures

Primary Outcomes (1)

  • Severity of PCS measured by the Rivermead Post-concussion Symptoms Questionnaire (RPQ)

    Self-rated post-concussion symptoms

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.

Secondary Outcomes (10)

  • Quality of life and overall functioning measured by Quality of Life After Brain Injury - Overall Scale (QOLIBRI) and Short Form health status questionnaire from the medical outcome status (SF-36).

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.

  • Subjective improvement measured by Patient Global Impression of Change (PGIC)

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.

  • Somatisation measured by Bodily Distress Syndrome Checklist (BDS checklist)

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.

  • Anxiety and depression severity measured by a subscale (SCL-8) of Symptom Check List, 90 items (SCL-90).

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint)and 15 months after baseline.

  • Health Anxiety measured by Whitely-8 index

    At baseline (i.e. at clinical assessment) and 3,6 (primary endpoint) and 15 months after baseline.

  • +5 more secondary outcomes

Study Arms (2)

Enhanced Usual Care (EUC)

ACTIVE COMPARATOR

Clinical psychiatric and neurological assessment. Information and advice.

Other: Enhanced Usual Care (EUC)

EUC + Early intervention programme

EXPERIMENTAL

Clinical psychiatric and neurological assessment. Information and advice. Individually targeted treatment programme.

Behavioral: EUC + Early intervention programme

Interventions

All patients will have a brief clinical psychiatric and neurological assessment in order to determine eligibility, and will be provided with information and advice about typical post-concussional symptoms, the typical recovery process and the use of pain medication.

Enhanced Usual Care (EUC)

All patients will have a brief clinical psychiatric and neurological assessment in order to determine eligibility, and will be provided with information and advice about typical post-concussional symptoms, the typical recovery process and the use of pain medication. The early intervention programme will be interdisciplinary and will mainly be provided by an occupational therapist and a physiotherapist under supervision of a neuropsychologist. It will be based on psychoeducation and principles from Cognitive Behavioral Therapy and Graded Exercise Therapy and targeted to patients' individual goals. Patients will receive 8 weekly treatment sessions (3 group based and 5 individual sessions). Intervention will start approximately 4-5 months after the concussion.

EUC + Early intervention programme

Eligibility Criteria

Age15 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Concussion caused by a head trauma according to the diagnostic criteria recommended by the Danish Consensus Report on Commotio Cerebri 5 within the last 2 - 6 months. The criteria is based on the diagnostic criteria recommended by the WHO Task Force 1, but with the amendment, that there must have been a direct contact between the head and an object in order to rule out acceleration - deceleration traumas.
  • Age between 15 and 30 years at the time of the head trauma.
  • Able to understand, speak and read Danish.
  • A score of 20 or more on the Rivermead Post Concussion Symptoms Questionnaire (RPQ).

You may not qualify if:

  • Objective neurological findings from neurological examination and / or acute trauma CT scan, indicating neurological disease or brain damage.
  • Previous concussion leading to persistent post-concussional symptoms within the last two years.
  • Severe misuse of alcohol, prescription drugs and / or illegal drugs.
  • Multiorgan Bodily Distress Syndrome (multiple somatic symptoms from various body sites and organ systems not related to the accident).
  • Psychiatric morbidity (Bipolar Disorder, severe Attention Deficit Hyperactivity Disorder, autism, psychotic disorder (life time)), or other psychiatric illness that impedes participation in the treatment.
  • Severe neurological disease and / or other medical disease that impedes participation in the treatment programme.
  • Significant learning and / or reading difficulties or mental retardation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, 8200, Denmark

Location

Related Publications (1)

  • Thastum MM, Rask CU, Naess-Schmidt ET, Tuborgh A, Jensen JS, Svendsen SW, Nielsen JF, Schroder A. Novel interdisciplinary intervention, GAIN, vs. enhanced usual care to reduce high levels of post-concussion symptoms in adolescents and young adults 2-6 months post-injury: A randomised trial. EClinicalMedicine. 2019 Dec 16;17:100214. doi: 10.1016/j.eclinm.2019.11.007. eCollection 2019 Dec.

Related Links

MeSH Terms

Conditions

Brain ConcussionPost-Concussion Syndrome

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Andreas Schröder, MD, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR
  • Charlotte U Rask, MD, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2015

First Posted

January 13, 2015

Study Start

March 1, 2015

Primary Completion

July 1, 2018

Study Completion

April 1, 2019

Last Updated

September 26, 2019

Record last verified: 2019-01

Locations